Bluejay Diagnostics, Inc. (BJDX)

0.6992 -0.0508 (-6.77%) 收市：04:00PM EDT

Bluejay Diagnostics, Inc.

360 Massachusetts Avenue
Suite 203
Acton, MA 01720
United States
844 327 7078
https://bluejaydx.com

版塊: Healthcare
行業: Medical Devices
全職員工: 10

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Indranil Dey	Principal Financial, Accounting & Executive Officer, President, CEO and Director	292.15k	無	1964
Dr. Jason Cook	Chief Technology Officer	240.29k	無	1983
Mr. Les DeLuca	Vice President of Operations	無	無	無
Eryn Graham	Marketing Manager	無	無	無
Mr. Kevin Vance	Chief Commercial Officer	無	無	1958
Mark W. Feinberg	Chief Medical Advisor	無	無	無
Dr. Mark W. Feinberg M.D.	Chief Medical Advisor	無	無	無
Ryan McSeveney	Corporate Controller	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

公司管治

截至 無 止，Bluejay Diagnostics, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。